Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells

Phytomedicine

Volumn 17, Issue 8-9, 2010, Pages 606-613

  Yue, Q X ^a,b   Song, X Y ^a,b   Ma, C ^a   Feng, L X ^a   Guan, S H ^a   Wu, W Y ^a   Yang, M ^a   Jiang, B H ^a   Liu, X ^a   Cui, Y J ^b   Guo, D A ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

2 DE; Chemoproteomic; Cytotoxicity; Ganoderic acids; Mass spectrometry

Indexed keywords

CELL PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DJ 1 PROTEIN; DJ 1 PROTEIN CHAIN A; GANODERIC ACID AM1; GANODERIC ACID B; GANODERIC ACID D; GANODERIC ACID F; GANODERIC ACID K; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR 5A; INTERLEUKIN 25; NUCLEOBINDIN 1; PEROXIREDOXIN 2; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE 2A SUBUNIT A PR65 ALPHA; PROTEIN 14 3 3 ALPHA; PROTEIN 14 3 3 BETA; RETICULOCALBIN 1; TPM4 ALK FUSION ONCOPROTEIN TYPE 2; TRITERPENE DERIVATIVE; UBIQUILIN 2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; FEMALE; GANODERMA LUCIDUM; HELA CELL; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOSIS INHIBITION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORESIS; FEMALE; HELA CELLS; HEPTANOIC ACIDS; HUMANS; INHIBITORY CONCENTRATION 50; PHYTOTHERAPY; PROTEINS; PROTEOME; REISHI; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRITERPENES; UTERINE CERVICAL NEOPLASMS;

EUKARYOTA; GANODERMA LUCIDUM;

EID: 77952290597     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.12.013     Document Type: Article

References (43)

1. Andres-Mateos E., Perier C., Zhang L., Blanchard-Fillion B., Greco T.M., Thomas B., Ko H.S., Sasaki M., Ischiropoulos H., Przedborski S., Dawson T.M., and Dawson V.L. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 104 (2007) 14807-14812
2. Chevallet M., Wagner E., Luche S., Dorsselaer A., Leize-Wagner E., and Rabilloud T. Regeneration of peroxiredoxins during recovery after oxidative stress. J. Biol. Chem. 278 (2003) 37146-37153
3. Du X.L., Hu H., Lin D.C., Xia S.H., Shen X.M., Zhang Y., Luo M.L., Feng Y.B., Cai Y., Xu X., Han Y.L., Zhan Q.M., and Wang M.R. Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J. Mol. Med. 85 (2007) 863-875
4. El-Mekkawy S., Meselhy M.R., Nakamura N., Tezuka Y., Hattori M., Kakiuchi N., Shimotohno K., Kawahata T., and Otake T. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry 49 (1998) 1651-1657
5. Hada H., Tokumoto W., and Namba T. Dental caries prevention by traditional medicines. XII. Effect of components of Ganoderma lucidum on glucosyltransferase from Streptococcus mutans. J. Med. Pharm. Soc. Wakan-Yaku 6 (1989) 100-107
6. Hall S.E. Chemoproteomics-driven drug discovery: addressing high attrition rates. Drug Discovery Today 11 (2006) 496-502
7. Hirotani M., Ino C., and Furuya T. Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum. Phytochemistry 33 (1993) 379-382
8. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem. J. 353 (2001) 417-439
9. Jao D.L., and Chen K.Y. Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging. J. Cell Biochem. 86 (2002) 590-600
10. Kimura Y., Taniguchi M., and Baba K. Antitumor and antimetastatic effects on liver triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of active substance. Anticancer Res. 22 (2002) 3309-3318
11. Kin D.H., Shi S.B., Kim N.J., and Jang O.S. b-Glucuronidaseinhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol. Pharm. Bull. 22 (1998) 162-164
12. Kohda H., Tokumoto W., Sakamoto K., Fujii M., Hirai Y., Yamasaki K., Komoda Y., Nakamura H., Ishihara S., and Uchida M. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem. Pharm. Bull. 33 (1985) 1367-1374
13. Lin C.N., Tome W.P., and Won S.J. Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod. 54 (1991) 998-1002
14. Lin L.J., Shiao M.S., and Yeh S.F. Seven new triterpenes from Ganoderma lucidum. J. Nat. Prod. 51 (1988) 918-924
15. Lin S.B., Li C.H., Lee S.S., and Kan L.S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci. 72 (2003) 2381-2390
16. Lin S.S., Bassik M.C., Suh H., Nishino M., Arroyo J.D., Hahn W.C., Korsmeyer S.J., and Roberts T.M. PP2A regulates BCL-2 phosphorylation and proteasome mediated degradation at the endoplasmic reticulum. J. Biol. Chem. 281 (2006) 23003-23010
17. Lin Z.B. Modern Research of Ganoderma lucidum. 2nd ed. (2001), Beijing Medical University Press pp. 7-9
18. Liu X., Fan X.L., Zhao Y., Luo G.R., Li X.P., Li R., and Le W.D. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. J. Neurosci. Res. 81 (2005) 653-665
19. Ma C., Guan S.H., Yang M., Liu X., and Guo D.A. Differential protein expression in mouse splenic mononuclear cells treated with polysaccharides from spores of Ganoderma lucidum. Phytomedicine 15 (2008) 268-276
20. Ma C., Yue Q.X., Guan S.H., Wu W.Y., Yang M., Jiang B.H., Liu X., and Guo D.A. Proteomic analysis of possible target-related proteins of cyclophosphamide in mice thymus. Food Chem. Toxicol. 47 (2009) 1841-1847
21. Min B.S., Gao J.J., Nakamura N., and Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48 (2000) 1026-1033
22. Min B.S., Gao J.J., Lee Y.H., Nakamura N., and Hattori M. Chemical and biological evaluation of germinated and mature antler-shaped fruiting bodies of Ganoderma lucidum. Nat. Med. 58 (2004) 91-97
23. Min B.S., Gao J.J., and Hattori M. Bitter principles from the fruiting bodies, cultural mycelia and spores of Ganoderma lucidum. Curr. Top. Phytochem. 7 (2005) 35-60
24. Morigiwa A., Kitabatake K., Fujimoto Y., and Ikekawa N. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem. Pharm. Bull. 34 (1986) 3025-3028
25. Noguchi M., Kakuma T., Tomiyasu K., Yamada A., Itoh K., Konishi F., Kumamoto S., Shimizu K., Kondo R., and Matsuoka K. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms. Asian J. Androl. 10 (2008) 777-785
26. Ozawa M., and Muramastsu T. Reticulocalbin, a novel endoplasmic reticulum resident Ca(2+)-binding protein with multiple EF-hand motifs and a carboxyl-terminal HDEL sequence. J. Biol. Chem. 268 (1993) 699-705
27. Roychoudhury P., and Chaudhuri K. Evidence for heterogeneous nuclear ribonucleoprotein K overexpression in oral squamous cell carcinoma. Br. J. Cancer 97 (2007) 574-575
28. Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini-Rev. Med. Chem. 4 (2004) 873-879
29. Sliva D. Ganoderma lucidum in cancer research. Leuk. Res. 30 (2006) 767-768
30. Toth J.O., Luu B., and Ourission G. Les acides ganoderiques taz: triterpenes cytotoxiques de Ganoderma lucidum (Polyporacee). Tetrahedron Lett. 24 (1983) 1081-1084
31. Tsukumo Y., Tomida A., Kitahara O., Nakamura Y., Asada S., Mori K., and Tsuruo T. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation. J. Biol. Chem. 282 (2007) 29264-29272
32. Tzivion G., Gupta V.S., Kaplun L., and Balan V. 14-3-3 proteins as potential oncogenes. Semin. Cancer Biol. 16 (2006) 203-213
33. Wachtel-Galor S., Tomlinson B., and Benzie I.F. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br. J. Nutr. 91 (2004) 263-269
34. Wagsater D., Lofgren S., Hugander A., and Dimberg J. Expression of interleukin-17 in human colorectal cancer. Anticancer Res. 26 (2006) 4213-4216
35. Wang X.M., Yang M., Guan S.H., Liu R.X., Xia J.M., Bi K.S., and Guo D.A. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J. Pharm. Biomed. Anal. 41 (2006) 838-844
36. Wang X.M., Liu R.X., Sun J.H., Guan S.H., Yang M., Bi K.S., and Guo D.A. HPLC method for the determination and pharmacokinetic studies of four triterpenoids in rat plasma after oral administration of Ganoderma lucidum extract. Biomed. Chromatogr. 21 (2007) 389-396
37. Wang X.M., Guan S.H., Liu R.X., Sun J.H., Liang Y., Yang M., Wang W., Bi K.S., and Guo D.A. HPLC determination of four triterpenoids in rat urine after oral administration of total triterpenoids from Ganoderma lucidum. J. Pharm. Biomed. Anal. 43 (2007) 1185-1190
38. Yang H.L. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402. Biotechnol. Lett. 27 (2005) 835-838
39. Yang M., Wang X., Guan S.H., Xia J.M., Sun J., Guo H., and Guo D.A. Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 18 (2007) 927-939
40. Yeung W.H., Lu Q.L., Zhang Q., and Go V.L.W. Chemical and biochemical basis of the potential anti-tumor properties of Ganoderma lucidum. Curr. Top. Nutraceutical Res. 2 (2004) 67-77
41. Yue Q.X., Cao Z.W., Guan S.H., Liu X.H., Tao L., Wu W.Y., Li Y.X., Yang P.Y., Liu X., and Guo D.A. Proteomic characterization of the cytotoxic mechanism of ganoderic acid D and computer automated estimation of the possible drug-target network. Mol. Cell Proteomics 7 (2008) 949-961
42. Yue Q.X., Xie F.B., Guan S.H., Ma C., Yang M., Jiang B.H., Liu X., and Guo D.A. Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenens. Cancer Sci. 99 (2008) 1461-1470
43. Yuen J.W., and Gohel M.D. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr. Cancer 53 (2005) 11-17